Búsqueda | Portal de Búsqueda de la BVS España

1.

Erlotinib in lung cancer - molecular and clinical predictors of outcome.

Tsao, Ming-Sound; Sakurada, Akira; Cutz, Jean-Claude; Zhu, Chang-Qi; Kamel-Reid, Suzanne; Squire, Jeremy; Lorimer, Ian; Zhang, Tong; Liu, Ni; Daneshmand, Manijeh; Marrano, Paula; da Cunha Santos, Gilda; Lagarde, Alain; Richardson, Frank; Seymour, Lesley; Whitehead, Marlo; Ding, Keyue; Pater, Joseph; Shepherd, Frances A.

N Engl J Med; 353(2): 133-44, 2005 Jul 14.

Artículo en Inglés | MEDLINE | ID: mdl-16014883

2.

OSI-930: a novel selective inhibitor of Kit and kinase insert domain receptor tyrosine kinases with antitumor activity in mouse xenograft models.

Garton, Andrew J; Crew, Andrew P A; Franklin, Maryland; Cooke, Andrew R; Wynne, Graham M; Castaldo, Linda; Kahler, Jennifer; Winski, Shannon L; Franks, April; Brown, Eric N; Bittner, Mark A; Keily, John F; Briner, Paul; Hidden, Chris; Srebernak, Mary C; Pirrit, Carrie; O'Connor, Matthew; Chan, Anna; Vulevic, Bojana; Henninger, Dwight; Hart, Karen; Sennello, Regina; Li, An-Hu; Zhang, Tao; Richardson, Frank; Emerson, David L; Castelhano, Arlindo L; Arnold, Lee D; Gibson, Neil W.

Cancer Res; 66(2): 1015-24, 2006 Jan 15.

Artículo en Inglés | MEDLINE | ID: mdl-16424037

3.

Incorporation of OSI-7836 into DNA of Calu-6 and H460 xenograft tumors.

Richardson, Frank; Black, Chris; Richardson, Katherine; Franks, April; Wells, Edward; Karimi, Susan; Sennello, Gina; Hart, Karen; Meyer, Denny; Emerson, David; Brown, Eric; LeRay, Jeremy; Nilsson, Christy; Tomkinson, Blake; Bendele, Raymond.

Cancer Chemother Pharmacol; 55(3): 213-21, 2005 Mar.

Artículo en Inglés | MEDLINE | ID: mdl-15592840

4.

Polymerization of the triphosphates of AraC, 2',2'-difluorodeoxycytidine (dFdC) and OSI-7836 (T-araC) by human DNA polymerase alpha and DNA primase.

Richardson, Katherine A; Vega, Tanya P; Richardson, Frank C; Moore, Chad L; Rohloff, John C; Tomkinson, Blake; Bendele, Raymond A; Kuchta, Robert D.

Biochem Pharmacol; 68(12): 2337-46, 2004 Dec 15.

Artículo en Inglés | MEDLINE | ID: mdl-15548380

5.

Evaluation of mitochondrial DNA content and enzyme levels in tenofovir DF-treated rats, rhesus monkeys and woodchucks.

Biesecker, Greg; Karimi, Susan; Desjardins, John; Meyer, Dennis; Abbott, Beth; Bendele, Ray; Richardson, Frank.

Antiviral Res; 58(3): 217-25, 2003 May.

Artículo en Inglés | MEDLINE | ID: mdl-12767469

6.

Support staff--asset or liability?

Richardson, Frank; Osborne, Darren.

Can Vet J; 48(1): 21-4, 2007 Jan.

Artículo en Inglés, Francés | MEDLINE | ID: mdl-17310620

7.

The evaluation of E-Cadherin and vimentin as biomarkers of clinical outcomes among patients with non-small cell lung cancer treated with erlotinib as second- or third-line therapy.

Richardson, Frank; Young, G David; Sennello, Regina; Wolf, Julie; Argast, Gretchen M; Mercado, Peter; Davies, Angela; Epstein, David M; Wacker, Bret.

Anticancer Res; 32(2): 537-52, 2012 Feb.

Artículo en Inglés | MEDLINE | ID: mdl-22287743

8.

CVMA practice model of efficiency.

Richardson, Frank; Osborne, Darren.

Can Vet J; 47(1): 35-7, 2006 Jan.

Artículo en Inglés, Francés | MEDLINE | ID: mdl-16536227

9.

Managing inventory costs.

Richardson, Frank; Osborne, Darren.

Can Vet J; 47(3): 277-8, 280, 282, 2006 Mar.

Artículo en Inglés, Francés | MEDLINE | ID: mdl-16604987

10.

Veterinary practice manager le gestionnaire vétérinaire.

Richardson, Frank; Osborne, Darren.

Can Vet J; 47(7): 702-6, 2006 Jul.

Artículo en Inglés, Francés | MEDLINE | ID: mdl-16898116

11.

Charting your accounts.

Richardson, Frank; Osborne, Darren.

Can Vet J; 47(5): 485-9, 2006 May.

Artículo en Inglés, Francés | MEDLINE | ID: mdl-16734378

12.

Model of practice excellence--budgeting with New Hamburg Veterinary Clinic.

Osborne, Darren; Richardson, Frank.

Can Vet J; 47(9): 923-4, 926, 928, 2006 Sep.

Artículo en Inglés, Francés | MEDLINE | ID: mdl-17017661

13.

Non-DVM staff: doing more with more.

Osborne, Darren; Richardson, Frank.

Can Vet J; 47(11): 1125-7, 2006 Nov.

Artículo en Inglés, Francés | MEDLINE | ID: mdl-17147147

14.

A randomized, phase II, biomarker-selected study comparing erlotinib to erlotinib intercalated with chemotherapy in first-line therapy for advanced non-small-cell lung cancer.

Hirsch, Fred R; Kabbinavar, Fairooz; Eisen, Tim; Martins, Renato; Schnell, Fredrick M; Dziadziuszko, Rafal; Richardson, Katherine; Richardson, Frank; Wacker, Bret; Sternberg, David W; Rusk, Jason; Franklin, Wilbur A; Varella-Garcia, Marileila; Bunn, Paul A; Camidge, Ross; Camidge, D Ross.

J Clin Oncol; 29(26): 3567-73, 2011 Sep 10.

Artículo en Inglés | MEDLINE | ID: mdl-21825259

15.

Risk management in the veterinary practice.

Richardson, Frank.

Can Vet J; 46(7): 655-8, 2005 Jul.

Artículo en Inglés, Francés | MEDLINE | ID: mdl-16152726

16.

Disaster recovery plan.

Richardson, Frank.

Can Vet J; 46(11): 1036-41, 2005 Nov.

Artículo en Inglés, Francés | MEDLINE | ID: mdl-16363333

17.

The valuation of a veterinary practice.

Richardson, Frank D.

Can Vet J; 46(3): 268-72, 2005 Mar.

Artículo en Inglés, Francés | MEDLINE | ID: mdl-15884652

18.

Adefovir nephrotoxicity and mitochondrial DNA depletion.

Bendele, Raymond A; Richardson, Frank C.

Hum Pathol; 33(5): 574, 2002 May.

Artículo en Inglés | MEDLINE | ID: mdl-12094387

19.

Novel application of layered expression scanning for proteomic profiling of plucked hair follicles.

Traicoff, June L; Baibakov, Galina; Biesecker, Greg; Richardson, Frank; Ramesh, Arun; Galperin, Mikhail M; Iwata, Kenneth K; Knezevic, Vladimir.

Dermatology; 210(4): 273-8, 2005.

Artículo en Inglés | MEDLINE | ID: mdl-15942212

20.

Mice deficient for cytosolic thymidine kinase gene develop fatal kidney disease.

Dobrovolsky, Vasily N; Bucci, Thomas; Heflich, Robert H; Desjardins, John; Richardson, Frank C.

Mol Genet Metab; 78(1): 1-10, 2003 Jan.

Artículo en Inglés | MEDLINE | ID: mdl-12559842

Portal de Búsqueda de la BVS España

Información y Conocimiento para la Salud

Configurar filtros

Su selección (0)

Formato de exportación:

Exportar:

Erlotinib in lung cancer - molecular and clinical predictors of outcome.

OSI-930: a novel selective inhibitor of Kit and kinase insert domain receptor tyrosine kinases with antitumor activity in mouse xenograft models.

Incorporation of OSI-7836 into DNA of Calu-6 and H460 xenograft tumors.

Polymerization of the triphosphates of AraC, 2',2'-difluorodeoxycytidine (dFdC) and OSI-7836 (T-araC) by human DNA polymerase alpha and DNA primase.

Evaluation of mitochondrial DNA content and enzyme levels in tenofovir DF-treated rats, rhesus monkeys and woodchucks.

Support staff--asset or liability?

The evaluation of E-Cadherin and vimentin as biomarkers of clinical outcomes among patients with non-small cell lung cancer treated with erlotinib as second- or third-line therapy.

CVMA practice model of efficiency.

Managing inventory costs.

Veterinary practice manager le gestionnaire vétérinaire.

Charting your accounts.

Model of practice excellence--budgeting with New Hamburg Veterinary Clinic.

Non-DVM staff: doing more with more.

A randomized, phase II, biomarker-selected study comparing erlotinib to erlotinib intercalated with chemotherapy in first-line therapy for advanced non-small-cell lung cancer.

Risk management in the veterinary practice.

Disaster recovery plan.

The valuation of a veterinary practice.

Adefovir nephrotoxicity and mitochondrial DNA depletion.

Novel application of layered expression scanning for proteomic profiling of plucked hair follicles.

Mice deficient for cytosolic thymidine kinase gene develop fatal kidney disease.